March 31, 2025 — Neuropathic pain affects up to 10 percent of the global population and can be challenging to manage effectively with existing medications.
April 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced that the FDA has approved an Investigational Device Exemption (IDE) application to initiate a pilot study for the treatment of patients with recurrent glioblastoma (GBM) using the Alpha DaRT technology.
March 28, 2025 — Novartis has announced that the US Food and Drug Administration (FDA) approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with an androgen receptor pathway inhibitor (ARPI) therapy and are considered appropriate to delay chemotherapy.
March 24, 2025 — The first X-ray machine to be used on astronauts in space features advanced detector technology developed in Canada. The SpaceXray research project is a collaboration between leading academic institutions, private companies and technology innovators across North America.
March 20, 2025 — GE HealthCare has launched InveniaAutomated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound offering advanced artificial intelligence (AI) and innovative features to drive faster*, reproducible supplemental screening and streamline exam readings on patients with dense breasts.
March 13, 2025 — Vave Health has introduced its Universal Wireless Probe. The probe is designed to enhance efficiency, accuracy, and diagnostics in a variety of clinical and educational settings. Its combination of linear and phased imaging technology provides high quality, full-body imaging with no ongoing subscription fees or hidden costs.
March 20 — Verasonics, Inc. recently announced the release of new features for the Vantage NXT Research Ultrasound System to advance ultrasound research and product development. The Vantage NXT update includes the release of the Acquisition SDK Programming Model and a 3 MHz matrix array transducer. This release will be available to all Vantage NXTcustomers on March 20, 2025.
March 18, 2025 — GE HealthCare recently announced a collaboration with NVIDIA expanding the existing relationship between the two companies to focus on innovation in autonomous imaging, beginning with autonomous X-ray technologies and autonomous applications within ultrasound.
March 18 — Perspectum has released the results of a multinational study showing that LiverMultiScancan reduce liver biopsies, lead to fewer specialist consultations, and improve the rate of diagnosis for patients with metabolic dysfunction-associated steatotic liver disease (MASLD). The study was published in Nature Communications Medicine and shows that MRI for patients with MASLD is cost-effective in Europe.
